Harnessing Supercomputer Power To Analyze And Model Proteins

A graphics supercomputer that for the first time combines high-speed computation, three-dimensional graphics, and molecular modeling and simulation software in a single interactive system was introduced last week at the American Chemical Society’s 3rd Chemical Congress in Toronto. The Molecular Simulator, targeted at biochemists, was jointly developed by hardware supplier Ardent Computer Corp. and software developer RioDesign, Inc. It can model and analyze the chemical structures of prot

Written byVicki Glaser
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A graphics supercomputer that for the first time combines high-speed computation, three-dimensional graphics, and molecular modeling and simulation software in a single interactive system was introduced last week at the American Chemical Society’s 3rd Chemical Congress in Toronto. The Molecular Simulator, targeted at biochemists, was jointly developed by hardware supplier Ardent Computer Corp. and software developer RioDesign, Inc. It can model and analyze the chemical structures of proteins and DNA that contain as many as 20,000 atoms.

“The closely coupled graphics and computational power of the Molecular Simulator make it practical, for the first time, to integrate display and analysis software with molecular structure and dynamics calculations in a single system,” says Thomas Steading, vice president of Ardent’s molecular sciences group.

The system features two application software packages from BioDesign: the BIOGRAF package applies to proteins, nucleic acids, lipids, and carbohydrates; the POLYGRAF package is useful for polymer and materials ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies